RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Herantis Pharma Oyj Stock

Herantis Pharma Oyj ROA 2024

Herantis Pharma Oyj ROA

0.04

Ticker

HRTIS.HE

ISIN

FI4000087861

In 2024, Herantis Pharma Oyj's return on assets (ROA) was 0.04, a -102.77% increase from the -1.5 ROA in the previous year.

Herantis Pharma Oyj Aktienanalyse

What does Herantis Pharma Oyj do?

Herantis Pharma Oyj ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Herantis Pharma Oyj's Return on Assets (ROA)

Herantis Pharma Oyj's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Herantis Pharma Oyj's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Herantis Pharma Oyj's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Herantis Pharma Oyj’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Herantis Pharma Oyj stock

What is the Return on Assets (ROA) of Herantis Pharma Oyj this year?

The Return on Assets (ROA) of Herantis Pharma Oyj is 0.04 undefined this year.

What was the ROA of Herantis Pharma Oyj compared to the previous year?

The ROA of Herantis Pharma Oyj has increased by -102.77% compared to the previous year.

What consequences do high ROA have for investors of Herantis Pharma Oyj?

A high ROA is advantageous for investors of Herantis Pharma Oyj, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Herantis Pharma Oyj?

A low ROA can be unfavorable for investors of Herantis Pharma Oyj as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Herantis Pharma Oyj affect the company?

An increase in ROA of Herantis Pharma Oyj can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Herantis Pharma Oyj impact the company?

A reduction in the ROA of Herantis Pharma Oyj can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Herantis Pharma Oyj?

Some factors that can influence the ROA of Herantis Pharma Oyj include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Herantis Pharma Oyj important for investors?

The ROA of Herantis Pharma Oyj is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Herantis Pharma Oyj take to improve ROA?

To improve ROA, Herantis Pharma Oyj can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Herantis Pharma Oyj pay?

Over the past 12 months, Herantis Pharma Oyj paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Herantis Pharma Oyj is expected to pay a dividend of 0 EUR.

What is the dividend yield of Herantis Pharma Oyj?

The current dividend yield of Herantis Pharma Oyj is .

When does Herantis Pharma Oyj pay dividends?

Herantis Pharma Oyj pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Herantis Pharma Oyj?

Herantis Pharma Oyj paid dividends every year for the past 0 years.

What is the dividend of Herantis Pharma Oyj?

For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.

In which sector is Herantis Pharma Oyj located?

Herantis Pharma Oyj is assigned to the 'Health' sector.

Wann musste ich die Aktien von Herantis Pharma Oyj kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Herantis Pharma Oyj from 11/9/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 11/9/2024.

When did Herantis Pharma Oyj pay the last dividend?

The last dividend was paid out on 11/9/2024.

What was the dividend of Herantis Pharma Oyj in the year 2023?

In the year 2023, Herantis Pharma Oyj distributed 0 EUR as dividends.

In which currency does Herantis Pharma Oyj pay out the dividend?

The dividends of Herantis Pharma Oyj are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Herantis Pharma Oyj

Our stock analysis for Herantis Pharma Oyj Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Herantis Pharma Oyj Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.